Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

October 26, 2025

Study Completion Date

December 31, 2025

Conditions
Brain TumorMedulloblastoma
Interventions
DRUG

[18F]DPA714

"Intravenous injection~* Before or within 2 weeks of starting radiation therapy~* Before starting chemotherapy~* 1 year after the start of radiation therapy Timing cont.~* 1.5 to 2 years after the start of radiation therapy"

Trial Locations (1)

38105

St.Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER